advertisement

---

Das S 10

Showing records 1 to 10 | Display all abstracts from Das S

106520 Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
Nivean PD
Indian Journal of Ophthalmology 2022; 70: 4164-4167

---

106135 Post-operative Day Zero Versus Day One Follow-Up for Uncomplicated Cataract Surgery
Patel V; Freedman RL
Cureus 2022; 14: e29286

---

106520 Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
Ariga M
Indian Journal of Ophthalmology 2022; 70: 4164-4167

---

106135 Post-operative Day Zero Versus Day One Follow-Up for Uncomplicated Cataract Surgery
Freedman RL; Freedman RL; Das S
Cureus 2022; 14: e29286

---

106520 Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
Chithra MR
Indian Journal of Ophthalmology 2022; 70: 4164-4167

---

106135 Post-operative Day Zero Versus Day One Follow-Up for Uncomplicated Cataract Surgery
Mansoor S
Cureus 2022; 14: e29286

---

106520 Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
Gohil P; Das S
Indian Journal of Ophthalmology 2022; 70: 4164-4167

---

106135 Post-operative Day Zero Versus Day One Follow-Up for Uncomplicated Cataract Surgery
Parekh H
Cureus 2022; 14: e29286

---

106520 Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
Jaideep G
Indian Journal of Ophthalmology 2022; 70: 4164-4167

---

106135 Post-operative Day Zero Versus Day One Follow-Up for Uncomplicated Cataract Surgery
Ridha F
Cureus 2022; 14: e29286

---